Announcement on Implementation of Dividend Distribution for 2024
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Dividend Distribution for 2024
Filed with SSE · · 4 pages · Chinese
Release
Hunan Fangsheng Pharmaceutical Co., Ltd. on 6ix
Earlier from Hunan Fangsheng Pharmaceutical
- Announcement on the Progress of Transferring Partial Equity of Holding Subsidiaries and Introducing Strategic Investors
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Results of Share Increase by Persons Acting in Concert with Controlling Shareholder
- Announcement on the Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stock
- Announcement on Resolutions of the 3rd Extraordinary Meeting of the 6th Board of Supervisors in 2025
Later from Hunan Fangsheng Pharmaceutical
- Announcement on Capital Increase to Holding Subsidiary and Related Party Transactions
- Announcement on Obtaining Drug Registration Certificate for Innovative Traditional Chinese Medicine Yangxue Qufeng Zhitong Granules
- Announcement on Progress of Drug Marketing Authorization Transfer
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary for Traditional Chinese Medicine Innovative Drug Research Project
- Announcement on Progress in Acquiring Pharmaceutical Production Technology
Follow Hunan Fangsheng Pharmaceutical into a list and get an email when it puts out news.
Follow Hunan Fangsheng Pharmaceutical